TIMOTHY CHILDERS: Open Payments
NPI 1124078555 · REED CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 26 payments from 10 companies in 2025. Trend: 2023 $1,098 · 2024 $1,449 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $164 |
| ABBVIE INC. | 9 | $155 |
| Neurocrine BioSciences, Inc. | 2 | $136 |
| Novo Nordisk Inc | 3 | $67 |
| PFIZER INC. | 2 | $42 |
| Exact Sciences Corporation | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
Products named: AIRSUPRA, QULIPTA, INGREZZA, Ozempic, Cologuard Collection Kit, REXULTI, Wegovy, PREVNAR 20.
Industry payments across MI — which companies pay providers there.
